Our Technology Can Help

Fully automated and entirely label-free, Clearbridge BioMedics’ ClearCell® FX1 System, with the patented microfluidic biochip, CTChip® FR1, the ClearCell® FX1 System achieves label-free CTC enrichment that better addresses the dynamic and complex nature of cancer. It even provides the potential for serial real-time treatment monitoring.

 

 

venn

Events
APR20-22THU - SAT
Cancer Metastasis 7th International Symposium 2017

20-22 APRIL 2017 | San Francisco, USA | Plenary Session

Learn More
Contact Us for more information